Trent Wang

3 weeks ago | nature.com | Denise Pereira |Trent Wang |Antonio Jiménez |Michael H Antoni |Maria Rueda-Lara |Emaan Nor Lehardy

TO THE EDITOR:There is no standardized approach for psychosocial assessments prior to bone marrow transplant across U.S. transplant centers, leading to inconsistencies in eligibility determination and patient support. While prior studies have highlighted disparities in access to hematopoietic stem cell transplantation (HSCT), research on the influence of individual and cultural factors on transplant completion remains limited [1, 2].

May 15, 2024 | nature.com | Trent Wang |Nausheen Ahmed |Andy Chen |Narendranath Epperla |Bradley M. Haverkos |Nasheed M. Hossain | +10 more

AbstractCD19 CAR T-cell (CAR-T) therapy is commonly administered to patients with relapsed or refractory large B-cell lymphomas (LBCL), but salvage or bridging therapy can sometimes lead to a complete response (CR) prior to infusion. Limited studies have assessed the outcomes of patients infused in CR. A total of 134 patients with LBCL in CR prior to CAR-T infusion were identified from the CIBMTR registry, with median prior lines of therapy of 3 (range 2–9).